A randomized trial evaluating the efficacy and safety of alirocumab in South Korea and Taiwan (ODYSSEY KT).
J Clin Lipidol
; 12(1): 162-172.e6, 2018.
Article
in En
| MEDLINE
| ID: mdl-29153823
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hypercholesterolemia
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
J Clin Lipidol
Journal subject:
BIOQUIMICA
/
METABOLISMO
Year:
2018
Document type:
Article
Country of publication:
Estados Unidos